Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
873.68
+0.56 (0.06%)
At close: Feb 21, 2025, 4:00 PM
872.29
-1.39 (-0.16%)
After-hours: Feb 21, 2025, 7:55 PM EST
Eli Lilly Revenue
In the year 2024, Eli Lilly had annual revenue of $45.04B with 32.00% growth. Eli Lilly had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.
Revenue (ttm)
$45.04B
Revenue Growth
+32.00%
P/S Ratio
17.47
Revenue / Employee
$958,355
Employees
47,000
Market Cap
784.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
| Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
| Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
| Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
| Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 41.95B |
LLY News
- 1 day ago - Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile - Reuters
- 1 day ago - Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall - CNBC
- 1 day ago - From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs - CNBC
- 2 days ago - These 12 stocks could be big winners if they make this one key move - Market Watch
- 3 days ago - Lilly to participate in TD Cowen's 45th Annual Health Care Conference - PRNewsWire
- 6 days ago - Top 5 growth stocks to watch in 2025 as market momentum builds - Invezz
- 9 days ago - Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs - Business Wire
- 11 days ago - AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer - Business Wire